Article citationsMore>>

Abdel-Aziz, M., Abdel-Hamid, S., Wahdan, O., et al. (2012) Phase II Trial: Undifferentiated versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver Cirrhosis. Stem Cell Reviews and Reports, 8, 972-981.
https://doi.org/10.1007/s12015-011-9322-y

has been cited by the following article:

• TITLE: Therapeutic Strategies of Stem Cell Transplantation for Liver Cirrhosis

  AUTHORS: Fan Chen

  KEYWORDS: Liver Cirrhosis, Stem Cell Therapy

  JOURNAL NAME: Yangtze Medicine, Vol.1 No.2, June 21, 2017

  ABSTRACT: Liver transplantation is widely regarded as the most effective therapy for end-stage liver diseases. However, stem cell-based therapy is being developed as a promising strategy which offers a number of benefits as it is minimally invasive and associated with low immunogenicity and low cost. This paper will review the major clinical issues surrounding the use of stem cell therapy for managing cirrhosis, such as discussing the selection of appropriate sub-types of bone marrow stem cells and the need for pre-differentiation into hepatocyte-like cells prior to transplantation, and providing an overview of the methods to improve cell viability and to prevent the exacerbation of cirrhosis. The role of human umbilical cord blood stem cells and amniotic epithelial cells for the treatment of liver disease will be also introduced.